Big pharma, Partnering, Pharma

Settlement agreement reached between pharma alliances, Mylan

Posted on 19 December 2013

Tags: , , , , ,

Mylan Pharmaceuticals and pharma alliances, Banner Pharmacaps have entered into a settlement and license agreement with Eisai and Valeant Pharmaceuticals.

It will resolve patent litigation related to Bexarotene Capsules, 75 mg.

Bexarotene is the generic version of TARGRETIN, which is indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.

Pursuant to the agreement of the pharma alliances, the pending litigation will be dismissed.

Mylan and Banner will receive a license to begin selling a generic version of the product on July 9, 2015.

All other terms and conditions of the settlement and license agreement are confidential.

View the full article at MarketWatch

For further deal information visit Current Agreements (subscription required)

 

Related

Report: Partnering Deals and Alliances with Mylan

Report: Partnering Deals and Alliances with Valeant Pharmaceuticals

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply